SAMHSA Email

FYI

From: Shalini Wickramatilake <SWickramatilake@nasadad.org>
Sent: Monday, May 11, 2020 6:02 PM
To: Shalini Wickramatilake <SWickramatilake@nasadad.org>
Cc: Shalini Wickramatilake <SWickramatilake@nasadad.org>
Subject: FW: Guidance for Law Enforcement and First Responders Administering Naloxone

State Directors and Component Group Members,

Please see below a notice from SAMHSA regarding guidance on first responder safety when administering naloxone amidst the COVID-19 pandemic.

Best,

Shalini

Shalini Wickramatilake-Templeman, MHS

Federal Affairs Manager

National Association of State Alcohol and Drug Abuse Directors

1919 Pennsylvania Avenue, NW

Suite M-250

Washington, DC 20036

Office: 202.292.4876

Cell: 703.717.8854

From: SAMHSA <noreply@health-emailupdates.com>
Sent: Monday, May 11, 2020 6:18 PM
To: Shalini Wickramatilake <SWickramatilake@nasadad.org>
Subject: Guidance for Law Enforcement and First Responders Administering Naloxone

Having trouble viewing this email? View it in your browser.

SAMHSA: Substance Abuse and Mental Health Services Administration

Guidance for Law Enforcement and First Responders Administering Naloxone

As the COVID-19 pandemic has spread throughout our country, SAMHSA has received reports that some first responders and law enforcement officers have been more reluctant to administer naloxone due to fear of potentially contracting the coronavirus. SAMHSA recognizes the concerns about COVID-19 exposure and recommends the following to promote first responder safety.

Substance Abuse & Mental Health Services Administration
5600 Fishers Lane | Rockville, MD 20857

1-877-SAMHSA-7 (1-877-726-4727) | www.samhsa.gov | Privacy

SAMHSA is a public health agency within the U.S. Department of Health and Human Services. Its mission is to reduce the impact of substance abuse and mental illness on America's communities.

This email was delivered to swickramatilake@nasadad.org.

Forwarded this by a friend? Subscribe and join over 250,000 people receiving the latest on substance use and mental health.